415-455-3237We Specialize in Cutting-edge, Minimally Invasive and Regenerative Procedures for Pain and Orthopedics.
CENTER FOR REGENERATIVE & INTERVENTIONAL SPINE AND SPORTS PAIN
Dr. Patel is a Harvard pain fellowship-trained physician who performs Minimally Invasive Spine and Orthopedic procedures, as well as advanced Regenerative Medicine techniques. His goal is to provide cutting-edge medical care painlessly and to get patients back to health and exercise. He has helped athletes and performers, including members from professional sports teams from St. Louis, the Atlanta Braves, Atlanta Hawks, and Cirque du Soleil.
For joints and tendon/ligament injuries, he performs procedures using platelet rich plasma (PRP), orthobiologic treatments using bone marrow concentrate and adipose tissue for spine and joint pain. He also performs conventional steroid injections, hyaluronic acid injections, radiofrequency ablation, and peripheral nerve stimulation.
For low back and neck pain, he also performs spine injections, electromyography, as well as minimally invasive spine endoscopic and percutaneous spine surgical procedures, posterior approach SI joint fusion, interspinous spacers, and spinal cord stimulation, as well as radiofrequency ablation.
He also performs sacral stimulation for pelvic pain and urinary or bowel incontinence, as well as endovenous treatments for incompetent veins/venous reflux.
He offers a holistic approach to pain treatment, and also offers acupuncture, bracing, behavioral health management and multimodal (non-opioid) analgesia.
He can be booked for an appointment by calling his office at 415-455-3237.
Dr. Rachita Navara is a bioengineer and cardiologist subspecializing in electrophysiology – debugging circuits in the heart. Her interest in EP emerged during bioengineering training at the innovative Olin College of Engineering, where she consulted for companies such as Boston Scientific and Preserve as an undergraduate student. In medical school at UT Southwestern, she harnessed her engineering skills to analyze intravascular ultrasound data and became a lead author on the four-year ACE-CTO clinical trial. In internal medicine residency at Stanford University, Dr. Navara was accepted into the inaugural Biodesign Pathway of Distinction and won first place for her innovative solution to post-cardiac arrest medication management. She was honored with multiple research awards and has been internationally recognized for her research on atrial fibrillation mechanisms.
Dr. Navara completed fellowship at Washington University in St. Louis, where she conducted research at the Center for Noninvasive Cardiac Radioablation. Her work uncovering mechanisms of novel noninvasive ablation and leading multiple sub-studies of the prospective Phase I/II clinical trial ENCORE-VT (Circulation 2019) led to a featured publication in Nature Communications and numerous first place awards through the Heart Rhythm Society and American College of Cardiology.
Dr. Navara’s company “SafeBeat Rx” is centered on improving the treatment of heart rhythm disorders. SafeBeat Rx was competitively selected into NSF I-Corps, MIT Engine startup development program, and BioGenerator’s Grants-to-business program. Dr. Navara was PI on her first NIH STTR grant submission as a cardiology fellow. She was appointed as the youngest member of the National ACC EP Leadership Council, and she is currently an HRS representative to the AMA. Dr. Navara’s lifelong passion is to apply her engineering background to transform arrhythmia management.
She can be booked for an appointment by calling his office at 415-455-3237.